Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularization.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Society of Nephrology. Clinical Journal

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2215/CJN.03140411PMID 21817131PMCID PMC3358992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention--effects on soluble CD40 ligand concentrations.

  2009cited by this paper
• Week-long high-maintenance dose clopidogrel regimen achieves better platelet aggregation inhibition than a standard loading dose before percutaneous coronary intervention: results of a double-blind, randomized clinical trial.

  2009cited by this paper
• The CD40/CD40 ligand system: linking inflammation with atherothrombosis.

  2009cited by this paper
• IL-8 amplifies CD40/CD154-mediated ICAM-1 production via the CXCR-1 receptor and p38-MAPK pathway in human renal proximal tubule cells.

  2009cited by this paper
• Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction.

  2009cited by this paper
• Renal artery stenting slows the rate of renal function decline

  2008cited by this paper
• The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: the PRINC (Plavix Response in Coronary Intervention) trial.

  2008cited by this paper
• Embolic Protection and Platelet Inhibition During Renal Artery Stenting

  2008cited by this paper
• The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study.

  2008cited by this paper
• Renal artery stenting slows the rate of renal function decline.

  2007cited by this paper
• Renal artery stenosis

  2007cited by this paper
• Anti‐platelet and anti‐thrombotic approaches in patients undergoing percutaneous coronary intervention

  2007cited by this paper
• Controversies in Renal Artery Stenosis: A Review by the American Society of Nephrology Advisory Group on Hypertension

  2007cited by this paper
• Survival in atherosclerotic renal artery stenosis: Its all about renal function, or is it?

  2007cited by this paper
• CD40/CD40L system and vascular disease

  2007cited by this paper
• TGF-Beta Treatment Modulates PD-L1 and CD40 Expression in Proximal Renal Tubular Epithelial Cells and Enhances CD8+ Cytotoxic T-Cell Responses

  2007cited by this paper
• Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin.

  2007cited by this paper
• CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn.

  2006cited by this paper
• Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.

  2006cited by this paper
• Immunohistochemistry of thrombi following iliac venous stenting: A novel model of venous thrombosis

  2006cited by this paper
• Assessing kidney function--measured and estimated glomerular filtration rate.

  2006cited by this paper
• ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent

  2006cited by this paper
• Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS).

  2006cited by this paper
• Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease.

  2006cited by this paper
• Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.

  2006cited by this paper
• Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.

  2006cited by this paper
• ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography

  2006cited by this paper
• Effectiveness of Management Strategies for Renal Artery Stenosis: A Systematic Review

  2006cited by this paper
• Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.

  2005cited by this paper
• CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates

  2005cited by this paper
• GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention

  2005cited by this paper
• GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention

  2004cited by this paper
• CD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet Activation

  2003cited by this paper
• CD40-CD40L and platelet function: beyond hemostasis.

  2003cited by this paper
• Soluble CD40 ligand in acute coronary syndromes.

  2003cited by this paper
• Soluble CD40 ligand in acute coronary syndromes.

  2003cited by this paper
• Soluble CD40 ligand in acute coronary syndromes.

  2003cited by this paper
• Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease.

  2003cited by this paper
• Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation

  2003cited by this paper
• Cardiopulmonary Bypass Induces Release of Soluble CD40 Ligand

  2002cited by this paper
• CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism

  2002cited by this paper
• Renal-artery stenosis.

  2001cited by this paper
• CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

  1998cited by this paper

• Emergent players in renovascular disease.

  2022cites this paper
• Renal Artery Stenosis in the Patient with Hypertension: Prevalence, Impact and Management

  2020cites this paper
• Renal Fibrosis Is Significantly Attenuated Following Targeted Disruption of Cd40 in Experimental Renal Ischemia

  2020cites this paper
• Soluble CD40 ligand expression in stable atherosclerosis: A systematic review and meta-analysis.

  2020cites this paper
• CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease

  2020cites this paper
• Emerging Paradigms in Chronic Kidney Ischemia.

  2018cites this paper
• Na/K-ATPase/src complex mediates regulation of CD40 in renal parenchyma

  2018cites this paper
• Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease

  2017cites this paper
• Mechanisms and treatments for renal artery stenosis.

  2013cites this paper
• Role of Distal Protection in Percutaneous Renal Intervention for Atherosclerotic Renovascular Disease

  2013cites this paper
• Effect of CD40 and sCD40L on Renal Function and Survival in Patients With Renal Artery Stenosis

  2013influential citation
• The Search for Reliable Markers for Increased Carotid Artery Stenting–Induced Cerebral Embolism

  2013cites this paper
• Current views on the management of atherosclerotic renovascular disease

  2012cites this paper
• Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.

  2012cites this paper
• Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin.

  2012cites this paper
• Effect of CD 40 and sCD 40 L on Renal Function and Survival in Patients With Renal Artery Stenosis

  year unknowncites this paper